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Fish and polyunsaturated fat intake and development of
allergic and nonallergic rhinitis
Jessica Magnusson, MSc,a Inger Kull, PhD,a,b,c Marit Westman, MD,d,e Niclas Hakansson, PhD,a Alicja Wolk, Dr Med Sci,a
Erik Melen, MD, PhD,a,c Magnus Wickman, MD, PhD,a,c and Anna Bergstr€om, PhDa Stockholm, SwedenBackground: Rhinitis is one of the most common diseases in
childhood. Fish, polyunsaturated fatty acid (PUFA), and
vitamin D intakes have been hypothesized to affect the risk of
allergic disease; however, it is unclear whether these are linked
to the development of rhinitis.
Objective: We sought to assess potential associations between
consumption of fish, dietary n-3 and n-6 PUFAs, and vitamin D
at age 8 years and development of allergic rhinitis (AR) and
nonallergic rhinitis (NAR) between the ages of 8 and 16 years.
Methods: We included 1970 participants from a birth cohort.
Data on dietary intake was obtained from a food frequency
questionnaire at age 8 years. The rhinitis definition was based
on questionnaires and IgE measures.
Results: The prevalence of rhinitis symptoms at age 8 years was
19% (n 5 380). Among the 1590 children without rhinitis
symptoms at age 8 years, 21% (n 5 337) had AR between ages 8
and 16 years, and 15% (n 5 236) had NAR. Regular intake of
oily fish and higher long-chain n-3 PUFA intake were associated
with a reduced risk of cumulative incidence of NAR (adjusted
odds ratio, 0.52 [95% CI, 0.32-0.87] for oily fish; odds ratio, 0.45
[95% CI, 0.30-0.67] for highest vs lowest tertile of long-chain n-
3 PUFAs; P trend < .001). The results for rhinitis, irrespective of
AR and NAR, were in line with the findings for NAR.
Conclusion: Regular consumption of oily fish and dietary
long-chain n-3 PUFAs in childhood might decrease the risk
of rhinitis, especially NAR, between the ages of 8 and 16 years.
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Rhinitis is one of the most common chronic diseases in
childhood.1,2 Noninfectious rhinitis can be distinguished into
allergic rhinitis (AR) and nonallergic rhinitis (NAR).3,4 In
adolescent populations with rhinitis, about 1 in 4 seem to have
NAR.5 A known risk factor for both AR and NAR is parental
allergic disease.6-8 However, few modifiable risk factors have
been identified, especially for NAR.6
Changes in dietary habits during the past decades, including
fish consumption, have been suggested to play a role in the
increase of allergic diseases, including rhinitis.9,10 Oily fish is rich
in long-chain n-3 polyunsaturated fatty acids (PUFAs) and
vitamin D, which have been suggested to decrease the risk of
allergic disease through their immunomodulatory properties,11,12
whereas n-6 PUFAs and an increased n-6/n-3 ratio have been
suggested to increase the risk.11
In some studies, including our birth cohort, regular intake of fish
in infancy has been associated with a reduced risk of rhinitis at
preschool age13-16 and up to age 12 years.17 The incidence of
rhinitis is high at school age and during adolescence,2,18 and there-
fore it is of interest to examinewhether school-age consumption of
fish, dietary PUFAs, and vitamin D can affect the risk of rhinitis.
Previous studies on fish and PUFA intake in school age have as-
sessed intake at the same time as the outcome, and in
these studies fish consumption has not been associated with
rhinitis,19-23 whereas studies on PUFA intake and rhinitis have
been inconclusive.24,25 Although few studies have examined the
association between vitamin D status and rhinitis in children, an
inverse association between vitamin D status at age 6 years and
rhinoconjunctivitis at age 14 years was recently observed in a
prospective cohort.26 In previous studies of the relation between
fish, PUFA, and vitamin D consumption and rhinitis in childhood,
IgE reactivity to common allergens has rarely been included in the
definition of rhinitis, which reduces the possibility of exploring
associations for AR and NAR separately.
In our birth cohort with longitudinal data, we examined potential
associations between fish intake, including types offish, dietary n-3
and n-6 PUFAs, and vitamin D, at age 8 years and cumulative
incidence of AR and NAR between ages 8 and 16 years.
METHODS
Study design and study population
This study is based on a population-based birth cohort, the Children,
Allergy, Milieu, Stockholm, an Epidemiological study (BAMSE), to which
4089 newborns were recruited between February 1994 and November 1996 in
Stockholm, Sweden. Baseline information was obtained through a parental
questionnaire shortly after birth, and follow-ups have taken place throughout1247
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studyFFQ: Food frequency questionnaireLA: Linoleic acidNAR: Nonallergic rhinitisOR: Odds ratioPUFA: Polyunsaturated fatty acidFIG 1. Flow chart of inclusion into the study population and analyses of the
cumulative incidence of AR and NAR between ages 8 and 16 years.childhood.27,28 The most recent follow-up took place at age 16 years;
adolescents answered a questionnaire, and the response rate compared with
the baseline cohort was 76%.
At 8 and 16 years of age, participants who answered the respective
questionnaire were invited to a clinical examination. At the 8-year examina-
tion, the child’s diet was assessed by using a food frequency questionnaire
(FFQ; n5 2614). At both ages 8 (n5 2470 [60%]) and 16 (n5 2547 [62%])
years, participants provided blood samples, which were analyzed for IgE
antibodies with ImmunoCAP to common inhalant allergens by using the
Phadiatop mix (birch, timothy, and mugwort pollen; cat, dog, and horse
dander; and Cladosporium herbarum and Dermatophagoides pteronyssinus;
Thermo Fisher Scientific, Uppsala, Sweden). Blood samples that scored pos-
itive for the Phadiatop mix were analyzed for allergen-specific IgE antibodies
to the single allergens mentioned above. A technical cutoff was set at an IgE
level of 0.35 kU/L or greater, according to the manufacturer’s instructions.
Participants with baseline questionnaire data, data on nutrient and total fish
intake at age 8 years, and outcome data at age 16 years were included in the
present study (n 5 1970, 48% of original cohort). Inclusion in the study is
described in detail in Fig 1. All parts of BAMSE have been approved by the
Ethics Committee of Karolinska Institutet, Stockholm, Sweden, and informed
consent from the study participants has been obtained.
Dietary assessment
Diet at age 8 years was assessed by using an FFQ with 98 foods and
beverages frequently consumed in Sweden. The participants were asked to
indicate how often on average they had consumed these in the previous
12 months, and 10 response categories were predefined (never, <1 time per
month, 1-3 times per month, 1 time per week, 2 times per week, 3-4 times
perweek, 5-6 times perweek, 1 time per day, 2 times per day, and >_3 times per
day). Most often the FFQwas filled out by a parent (57%) or a parent together
with the child (40%). With regard to fish consumption, participants were
asked about intake of herring/mackerel and salmon fishes (categorized as
oily fish), as well as codfish/pollock/pike, fish fingers, and tuna fish. Intakes
of dietary PUFA and vitamin Dwere computed from the FFQ by multiplying
the frequency of consumption of each food item by its nutrient content per
serving and summarized over food and beverages by using composition
values obtained from the Swedish Food Administration Database.29 Nutrient
intakes were adjusted for total energy intake by using the residuals method.30
PUFAs assessed were linoleic acid (LA; 18:2n-6), a-linolenic acid (ALA;
18:3n-3), arachidonic acid (AA; 20:4n-6), eicosapentaeonic acid (20:5n-
3), docosapentaenoic acid (22:5n-3), and docosahexaeonic acid (22:6n-3).Definition of outcomes
Rhinitis symptoms at age 8 years. These symptoms included
parent-reported sneezing or runny or blocked nosewithout common cold or flu
in the last 12 months and/or nose or eye symptoms in contact with furred pets
and/or pollens after 4 years of age.3
AR at age 16 years. AR included adolescent-reported sneezing or
runny or blocked nose without common cold or flu or in contact with furred
pets, pollens, and/or mites in the last 12 months in combination with
sensitization to any of the inhalant allergens tested (Phadiatop >_0.35 kU/L).3NAR at age 16 years. NAR included adolescent-reported
symptoms as above with no sensitization (Phadiatop <0.35 kU/L).3
Statistical analyses
The distribution of selected background characteristics for the study
population and for the total cohort was compared with a 1-sample t test.
Fish intake was divided into dichotomous variables less than 2 times a week
or 2 or more times a week for total fish and less than 1 time a week or 1 or
more times a week for oily fish, cod/pollock/pike, and fish fingers. PUFA
and vitamin D intakes were divided into tertiles. PUFAs were analyzed as
single fatty acids (ALA, LA, and AA) and grouped together to total PUFA,
n-6 (LA and AA), and long-chain n-3 (docosahexaeonic acid, eicosapen-
taeonic acid, and docosapentaenoic acid) PUFAs. We also analyzed the n-6/
n-3 ratio. The outcome was analyzed as the cumulative incidence of AR and
NAR between ages 8 and 16 years by excluding children with rhinitis
symptoms at age 8 years (n5 380, Fig 1), and the reference category consisted
of adolescents with no rhinitis symptoms and no sensitization to inhalant
allergens at age 16 years. Analyses of associations between exposure and
outcome were done with multinomial logistic regression. The results are
presented as adjusted odds ratios (ORs) with 95% CIs. Tests for trends in
analyses of PUFA and vitamin D intakewere performed, assigning the median
value of each tertile to all subjects in that tertile, which then was used as a
continuous variable in the model.
Traditional potential confounding factors for which we tested were sex,
allergic heredity, maternal age, maternal smoking during pregnancy or the
child’s first months, older siblings and socioeconomic status (baseline
questionnaire), breast-feeding duration and fish consumption in infancy
(1-year questionnaire), and parental origin, indoor moist, furred pet
ownership, parental smoking, socioeconomic status, energy intake,
supplement use, and overweight status (8-year questionnaire). In the first
step analyses were unadjusted because no factor changed crude ORs by 5% or
greater. In a second step food groups (total intake of dairy products, meat,
cereals, fruits, and vegetables) were tested as potential confounding factors in
analyses of fish intake. No food group changed crude ORs by 5% or greater,
and fish analyses were only adjusted for the other types of fish. In addition, in
analyses of PUFAs and vitamin D, nutrients were tested as possible
TABLE I. Distribution of selected exposure characteristics in the study population (n5 1970) and among adolescents with incident
AR (n 5 337) or NAR (n 5 236) between ages 8 and 16 years
Study population* Incident ARy Incident NARz
No. Percent No. Percent No. Percent
Male sex 970 49.2 183 54.3 102 43.2
Maternal smoking,§ yes 233 11.8 37 11.0 46 19.5
Maternal age at birth <_25 y 134 6.8 21 6.2 22 9.3
Breast-feeding >_4 mo 1578 81.4 271 81.1 188 81.7
Parental origin,k outside of Scandinavia 407 20.8 87 25.9 51 21.7
Socioeconomic status, white collar worker 1675 85.9 293 88.3 185 79.4
Allergic heredity,{ yes 625 32.0 136 40.6 53 22.7
Eczema at age 1 y, yes 312 16.0 60 18.0 27 11.7
Any wheeze at age 1 y, yes 280 14.5 54 16.2 36 15.6
Fish intake at age 1 y, >_2 times/mo 1560 80.5 252 75.5 188 81.4
Parental smoking,# yes 324 16.6 45 13.4 51 21.8
Obesity at age 8 y,** yes 75 3.8 16 4.8 10 4.2
Supplement use at age 8 y, yes 825 42.4 134 40.0 108 46.2
Sensitization to inhalant allergens at age 8 y, yes 493 26.3 163 50.6 2 0.9
Mean SD Mean SD Mean SD
Energy intake at age 8 y (kcal) 1910 462 1917 434 1923 500
*Subjects fulfilling the inclusion criteria: baseline questionnaire data, data on nutrient and total fish intake at age 8 years, and outcome data at age 16 years.
Adolescents fulfilling the inclusion criteria as above and: do not have rhinitis symptoms at age 8 years and have AR at age 16 years.
Adolescents fulfilling the inclusion criteria as above and: do not have rhinitis symptoms at age 8 years and have NAR at age 16 years.
§Mother smoked at least 1 cigarette per day at any point of time during pregnancy or the child’s first months.
kFather and/or mother born outside of Scandinavia.
{Doctor-diagnosed asthma and/or hay fever in combination with reported allergy to pollen or pets in 1 or both parents.
#Any of the parents smoked at least 1 cigarette per day when the child was age 8 years.
**The child had an isoBMI of at least 30 kg/m2 at age 8 years (age and sex specific cut-off values developed for children under 18 years of age).
The child used supplements, such as multivitamins, sometimes or regularly at age 8 years.
The child had at least 1 IgE value of 0.35 kU/L or greater against inhalant allergens at age 8 years.
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unsaturated fat, total antioxidant capacity, and other exposures in respective
analyses). Carbohydrates, monounsaturated fat, vitamin D, and the other
group of PUFAs changed crude ORs by 5% or greater and were therefore
adjusted for in the respective PUFA intake analysis, and vitamin D analyses
were adjusted for carbohydrates, monounsaturated fat, and PUFAs. To control
for possible disease-related modification of exposure, we additionally
adjusted the analyses for early symptoms of allergic disease (children with
reported symptoms of wheeze, eczema, or both during the first 2 years of life).
Possible interactions between types of fish, PUFAs, and vitamin D and allergic
hereditywere testedwith the likelihood ratio test. Data analyseswere executed
with Stata version 11.2 software (StataCorp, College Station, Tex).
RESULTS
There were only minor differences in the distribution of
background characteristics between the 1970 adolescents in the
study population and the baseline cohort (see Table E1 in this ar-
ticle’s Online Repository at www.jacionline.org).
The prevalence of rhinitis symptoms at age 8 years was 19%
(n 5 380). Among the 1590 without rhinitis symptoms at age
8 years, 337 adolescents (21%) had AR between ages 8 and
16 years, and 236 (15%) had NAR. Adolescents who had AR or
NARhad somewhat different background characteristics (Table I).
For example, participants with incident AR had a higher preva-
lence of allergic heredity and more reported eczema in infancy.
The largest difference was seen for sensitization to inhalant aller-
gens at age 8 years (ie, 51%with an incidence ofARat age 16 years
were sensitized at age 8 years compared with 1% with NAR).
Median intakes of fish and nutrients for the study population, as
well as for the adolescents with incident AR or NAR, are
described in Table II. At age 8 years, 38% of the study population
had a fish intake of 2 times per week or more. Fourteen percent
consumed oily fish once a week or more, and the correspondingpercentages for cod/pollock/pike and fish fingers were 32% and
38%, respectively. The median intake of total PUFAs
was 7.85 g/d, whereas the median intake of vitamin D was
5.12 mg/d. Distribution of disease in relation to fish, PUFA, and
vitamin D intake at age 8 years is described in Table E2 in this ar-
ticle’s Online Repository at www.jacionline.org. A regular intake
of fish at age 8 years was not significantly associated with risk of
AR or NAR at the same age (adjusted OR, 1.04 [95% CI, 0.71-
1.54] for AR; adjusted OR, 0.80 [95% CI, 0.43-1.48] for NAR).
In multivariate logistic regression analysis there was no
apparent association between intake of total fish at age 8 years
and cumulative incidence of AR and NAR between the ages of 8
and 16 years (Table III). In analyses based on type of fish, a
regular intake of oily fish was associated with a reduced risk of
cumulative incidence of NAR between ages 8 and 16 years
(adjusted OR, 0.52 [95% CI, 0.32-0.87]), whereas the association
with AR was in the same direction but did not reach statistical
significance (adjusted OR, 0.78 [95% CI, 0.53-1.15]). There
were no evident associations for cod/pollock/pike or fish fingers
and AR or NAR. Adjusting for early symptoms of allergic disease
to avoid disease-related modification of exposure did not affect
the observed ORs (data not shown).
Long-chain n-3 PUFA intake was associated with a significant
reduced risk of cumulative incidence of NAR between ages 8 and
16 years (adjusted OR, 0.45 [95%CI, 0.30-0.67] for the highest vs
lowest tertile; P trend < .001). In addition, an increased n-6/n-3
ratio was associated with an increased risk of cumulative inci-
dence of NAR (adjusted OR, 1.56 [95%CI, 1.03-2.33] for highest
vs lowest tertile;P trend5 .032). No significant associations were
observed for intake of total PUFA, total n-6 PUFA, and the single
fatty acids LA and ALA and cumulative incidence of AR and
NAR (Table IV). Additional adjustment for early symptoms of
TABLE III. ORs of AR or NAR between ages 8 and 16 years*y in relation to fish intake at age 8 yearsz (n 5 1590)
Incident AR Incident NAR
Crude OR§ (95% CI) Adjusted ORk (95% CI) Crude OR§ (95% CI) Adjusted ORk (95% CI)
Total fish{
>_2 Times/wk 1.04 (0.80-1.35) — 0.98 (0.72-1.32) —
Oily fish
>_1 Time/wk 0.78 (0.53-1.14) 0.78 (0.53-1.15) 0.59 (0.37-0.95) 0.52 (0.32-0.87)
Cod/pollock/pike
>_1 Time/wk 0.95 (0.72-1.26) 0.93 (0.69-1.25) 1.10 (0.81-1.51) 1.15 (0.82-1.61)
Fish fingers
>_1 Time/wk 1.21 (0.93-1.57) 1.26 (0.95-1.66) 1.06 (0.79-1.44) 1.04 (0.75-1.44)
P values of .05 or smaller are considered significant and shown in boldface.
*No rhinitis symptoms at age 8 years.
The reference group in analyses is composed of adolescents without sensitization and rhinitis symptoms at age 16 years.
Fish intake at age 8 years is based on answers to an FFQ.
§Unadjusted model.
kModel including the variables oily fish, cod/pollock/pike, and fish fingers at once.
{Total fish is the sum of the variables oily fish, cod/pollock/pike, and fish fingers.
TABLE II. Consumption of fish and unadjusted PUFAs and vitamin D at age 8 years for the study population (n 5 1970) and
adolescents with an incident AR (n 5 337) and NAR (n 5 236) between ages 8 and 16 years
Study population Incident AR Incident NAR
Median IQR Minimum-maximum Median IQR Minimum-maximum Median IQR Minimum-maximum
Fish intake (times/wk)
Total fish 1.70 1.23 0-14.6 1.70 1.23 0-7.9 1.63 1.28 0-6
Oily fish 0.47 0.47 0-7.1 0.47 0.47 0-4.5 0.47 0.47 0-3
Cod/pollock/pike 0.47 0.88 0-7 0.47 0.88 0-2 0.47 0.88 0-2
Fish fingers 0.47 0.53 0-7 0.47 0.53 0-7 0.47 0.53 0-2
PUFA intake (g/d)
Total PUFA 7.85 3.12 3.0-25.1 7.89 2.98 3.2-19.4 7.98 3.28 3.3-16.2
ALA 1.13 0.50 0.4-4.1 1.13 0.47 0.4-3.2 1.15 0.62 0.4-3.1
Long-chain n-3 PUFA* 0.24 0.17 0.01-2.5 0.24 0.16 0.03-0.9 0.21 0.17 0.03-0.8
n-6 PUFA 6.22 2.45 2.4-20.1 6.28 2.35 2.4-15.9 6.21 2.70 2.7-13.7
LA 6.15 2.43 2.3-20.0 6.20 2.35 2.4-15.9 6.15 2.63 2.7-13.6
AA 0.07 0.03 0.005-0.4 0.07 0.04 0.02-0.4 0.07 0.04 0.02-0.2
n-6/n-3 ratio 4.58 0.76 1.4-11.2 4.62 0.69 2.8-8.5 4.65 0.72 3.1-11.2
Vitamin D intake (mg/d) 5.12 2.58 0.9-17.5 5.11 2.48 1.2-12.2 5.27 2.47 1.1-12.4
*Eicosapentaeonic, docosapentaenoic, and docosahexaeonic acid.
LA and AA.
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shown). We did not observe any obvious associations between
intake of vitamin D and cumulative incidence of AR or NAR be-
tween ages 8 and 16 years (Table IV). There were no significant
interactions between allergic heredity and intake of fish, PUFAs,
and vitamin D with respect to the incidence of AR or NAR (data
not shown).
Because the results for AR and NAR pointed in the same
direction, we performed post hoc analyses by using AR and
NAR cases combined to increase the comparability with the
results from other studies (Fig 2). The results obtained were
comparable with those for NAR in Tables III and IV; regular
oily fish intake and dietary long-chain n-3 PUFAs were
associated with a decreased risk of cumulative incidence of
rhinitis between ages 8 and 16 years (adjusted OR, 0.67
[95% CI, 0.48-0.94] for oily fish; adjusted OR, 0.73 [95% CI,
0.55-0.98] for highest vs lowest tertile of long-chain n-3
PUFA; P trend 5 .034), and the n-6/n-3 ratio was borderline
significantly associated with an increased risk of cumulative
incidence of rhinitis (adjusted OR, 1.28 [95% CI, 0.96-1.74]
for highest vs lowest tertile; P trend 5 .100).DISCUSSION
In our study of 1970 adolescents from the birth cohort BAMSE,
regular intake of oily fish and dietary long-chain n-3 PUFAs
measured at age 8 years was associated with a reduced risk of
cumulative incidence of NAR between ages 8 and 16 years. In
addition, an increased n-6/n-3 ratio was associated with an
increased risk of cumulative incidence of NAR. The results for
rhinitis,whetherARorNAR,were comparablewith those forNAR.
In contrast to our findings, other studies on fish and PUFA
consumption in childhood have not observed an associa-
tion20,21,23,24 or increased risk24,25 of rhinitis. Discrepancy
between other studies on rhinitis and our findings can be due to
a number of factors, including PUFA categorization (total
PUFAvs n-3 and n-6 PUFA or single fatty acids). In adults inverse
associations between long-chain n-3 PUFAs and rhinitis have
been reported,31,32 although another study did not observe any
associations.33 These studies were all of a cross-sectional design.
In our cross-sectional analysis of oily fish intake andAR andNAR
at age 8 years, we observed no associations.
Oily fish might influence allergic disease through its content of
long-chain n-3 PUFAs. Long-chain n-3 PUFAs have been shown
TABLE IV. ORs of AR or NAR between ages 8 and 16 years*y in relation to dietary PUFA (in grams per day) and vitamin D (in
micrograms per day) intake in tertiles at age 8 years (n 5 1590)
Incident AR Incident NAR
Crude ORz (95% CI) Adjusted OR§ (95% CI) Crude ORz (95% CI) Adjusted OR§ (95% CI)
Total PUFA
Q2 0.93 (0.68-1.28) 0.88 (0.62-1.25) 0.94 (0.66-1.34) 0.83 (0.56-1.22)
Q3 0.95 (0.69-1.29) 0.85 (0.57-1.28) 0.87 (0.61-1.24) 0.69 (0.43-1.11)
P value for trendk .757 .478 .448 .127
ALA
Q2 0.84 (0.61-1.15) 0.80 (0.55-1.15) 1.08 (0.75-1.54) 1.06 (0.70-1.60)
Q3 0.86 (0.63-1.18) 0.80 (0.50-1.28) 0.98 (0.69-1.41) 0.89 (0.52-1.53)
P value for trendk .383 .376 .890 .643
Long-chain n-3 PUFA
Q2 0.84 (0.61-1.15) 0.87 (0.63-1.20) 0.64 (0.45-0.90) 0.62 (0.44-0.88)
Q3 0.95 (0.70-1.30) 1.02 (0.72-1.44) 0.48 (0.33-0.70) 0.45 (0.30-0.67)
P value for trendk .794 .922 <.001 <.001
n-6 PUFA
Q2 0.96 (0.70-1.31) 0.97 (0.66-1.42) 0.98 (0.69-1.40) 0.91 (0.59-1.40)
Q3 0.91 (0.67-1.25) 0.88 (0.54-1.43) 0.91 (0.64-1.30) 0.86 (0.50-1.49)
P value for trendk .557 .239 .589 .374
LA
Q2 0.97 (0.71-1.32) 1.00 (0.68-1.46) 0.98 (0.69-1.40) 0.92 (0.59-1.41)
Q3 0.93 (0.68-1.27) 0.92 (0.57-1.60) 0.91 (0.64-1.30) 0.86 (0.50-1.50)
P value for trendk .634 .714 .588 .606
AA
Q2 0.91 (0.66-1.25) 0.89 (0.64-1.25) 0.68 (0.48-0.97) 0.76 (0.52-1.10)
Q3 1.06 (0.78-1.46) 1.01 (0.69-1.49) 0.82 (0.58-1.17) 1.02 (0.66-1.57)
P value for trendk .639 .890 .340 .855
n-6/n-3 ratio
Q2 1.24 (0.91-1.70) 1.22 (0.88-1.68) 1.47 (1.02-2.11) 1.50 (1.02-2.18)
Q3 1.16 (0.85-1.59) 1.12 (0.79-1.59) 1.50 (1.04-2.15) 1.56 (1.03-2.33)
P value for trendk .343 .511 .031 .032
Vitamin D
Q2 0.94 (0.69-1.29) 0.96 (0.70-1.33) 0.80 (0.56-1.15) 0.97 (0.67-1.42)
Q3 0.82 (0.60-1.13) 0.85 (0.59-1.21) 0.93 (0.66-1.32) 1.27 (0.85-1.89)
P value for trendk .228 .370 .715 .236
P values of .05 or smaller are considered significant and shown in boldface.
*No rhinitis symptoms at age 8 years.
The reference group in analyses is composed of adolescents without sensitization and rhinitis symptoms at age 16 years.
Unadjusted model.
§Model adjusted for intakes of carbohydrates, monounsaturated fatty acids, vitamin D, and the other fatty acids used as exposures at age 8 years.
kTest for trend with median value of each exposure category.
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increase the level of anti-inflammatory mediators, whereas n-6
PUFAs promote formation of inflammatory mediators.11 There-
fore higher intake of n-6 and lower intake of n-3 PUFAs might
lead to a higher risk of inflammation. We observed the strongest
associations between oily fish, long-chain n-3 PUFAs, and
NAR. NAR does not involve IgE mediation but is a nasal mucosal
inflammation caused by nonimmunologic factors, and its specific
mechanisms are not fully understood.34 Allergic heredity and
sensitization to inhalant allergens are strong determinants of
AR, as observed in a previous report from our cohort, as well as
other reports.3,7,8 In the current study 51% of the adolescents
with AR between ages 8 and 16 years were sensitized to inhalant
allergens at age 8 years. Thus there might be less room for modifi-
able factors, such as diet, to influence the risk of AR to a great
extent.
Another possible mechanism proposed to link oily fish and
allergic disease is through vitamin D, which is known to have
immunomodulatory properties.12 However, we did not observe
any associations between dietary vitamin D levels and AR orNAR, which might be because of the general low levels of intake
in our subjects. Although the median intake in our study popula-
tion was slightly higher compared with that of children of the
same age in a Swedish national survey (5.1 vs 4.3 mg/d),35 only
14% reached the Nordic recommendation of an average vitamin
D intake of 7.5 mg/d.36 In addition, dietary intake is only one
part that affects vitamin D status, which is highly determined
by sun exposure.12 Therefore most studies on vitamin D levels
and allergic disease in childhood have used blood levels of
vitamin D, and unfortunately, serum levels were not available in
our cohort.
The strengths of the present study include its prospective
longitudinal design with repeated data on rhinitis symptoms,
which made it possible to study the cumulative incidence of
disease. We had the opportunity to distinguish between AR and
NAR by including an objective measure of sensitization to
inhalant allergens to the outcome definition. We were also able
to distinguish between oily and lean fish and consider both
vitamin D and types of PUFAs. Moreover, we could account for a
large number of potential confounders, such as infant fish intake
FIG 2. Intake of oily fish and PUFAs at age 8 years in relation to the
cumulative incidence of rhinitis between ages 8 and 16 years. Cases of AR
and NARwere analyzed together. Adjusted ORs and 95% CIs were obtained
by using logistic regression.
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out that unmeasured factors have introduced residual confound-
ing, such as maternal fish intake during pregnancy, which has
been associated with a decreased risk of allergic disease during
childhood, although primarily up to preschool age.37,38
Limitations include the possibility of selection bias because
we include only 48% of the baseline cohort. However, in
comparison with the baseline cohort, there are only minor
differences in distribution of background factors for our included
study population. Another possible limitation is misclassification
of the NAR outcome; it is difficult to disentangle true NAR from
long-lasting symptoms after an upper respiratory tract infection.
However, the definition we use for NAR includes rhinitis
symptoms according to the International Study of Asthma and
Allergy in Children18 or symptoms after exposure to pollen or
furred animals. Another concern is that the adolescents classified
as having NARmight be sensitized to an inhalant allergen that we
have not measured, although sensitization was measured with
Phadiatop, which includes the 8 most common inhalant allergens
in our region. However, some of the adolescents with NAR symp-
toms might have local AR not captured with Phadiatop.39
Despite these concerns, the 15% classified as having NAR in
our study population correspond to the number suggested by
Lieberman and Pattanaik.40 In total, 36% were classified as
having rhinitis (either AR or NAR), which is in line with other
studies on adolescents.41,42
Misclassification of exposure is also possible. The FFQ is not a
perfect tool for assessing food consumption and will probably not
capture the absolute intake. Nevertheless, because we categorize
intake instead of using the absolute value, this is a minor problem
as long as the possible misclassification is nondifferential, which
is probable because we study food consumption measured before
disease development. In addition, fish consumption in the study
population was in line with data from a Swedish national survey
for the same age category (1.70 vs 1.75 times per week),35
whereas PUFA levels were only slightly higher in the included
study population compared with those in children of comparable
age (8.3 vs 7 g/d).35
In conclusion, our study of 1970 subjects from the Swedish
birth cohort BAMSE revealed that a regular intake of oily fish anddietary long-chain n-3 PUFAs in childhood might decrease the
risk of cumulative incidence of rhinitis between the ages of 8 and
16 years, especially NAR, whereas an increased n-6/n-3 ratio
seemed to increase the risk. Although the support from
other epidemiologic studies for this association is limited, the
association is biologically plausible. However, further studies are
needed to disentangle the possible mechanisms behind these
observations. Consuming oily fish at least once per week is
consistent with the current dietary guidelines to consume varying
types of fish at least twice a week. Thus our study provides
additional support for these recommendations.
Wewould like to express our sincere gratitude to all the children and parents
contributing to the BAMSEbirth cohort.We also thank theBAMSE secretariat
for their invaluable work with data collection and management.
Clinical implications: Regular oily fish consumption in child-
hood might decrease the risk of rhinitis up to age 16 years,
possibly because of its content of long-chain n-3 PUFAs.REFERENCES
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TABLE E1. Distribution of selected exposure characteristics in the cohort (n 5 4089) and study population (n 5 1970)
Total cohort Study population*
No. Percent No. Percent 95% CIy
Male sex 2065 50.5 970 49.2 47.7-50.8
Maternal smoking, yes 563 13.8 233 11.8 10.8-12.9
Maternal age at birth <_25 y 319 7.8 134 6.8 6.0-7.7
Breast-feeding >_4 mo 3116 79.5 1578 81.4 80.2-82.6
Parental origin,§ outside of Scandinavia 707 20.8 407 20.8 19.6-22.0
Socioeconomic status, white collar worker 3323 82.7 1675 85.9 84.7-86.9
Allergic heredity,k yes 1200 29.7 625 32.0 30.5-33.5
Eczema at age 1 y, yes 594 15.1 312 16.0 15.0-17.3
Any wheeze at age 1 y, yes 577 14.7 280 14.5 13.4-15.6
Fish intake at age 1 y, >_2 times/mo 3143 80.1 1560 80.5 79.2-81.7
Parental smoking,{ yes 597 17.7 324 16.6 15.6-17.7
Obesity at age 8 y,# yes 116 4.4 75 3.8 3.4-4.3
Supplement use at age 8 y,** yes 1082 42.0 825 42.4 41.3-43.4
Sensitization to inhalant allergens at age 8 y, yes 637 26.0 493 26.3 25.3-27.2
Mean SD Mean SD 95% CI
Energy intake at age 8 y (kcal) 1905 468 1910 462 1900-1920
*Subjects fulfilling the inclusion criteria: baseline questionnaire data, data on nutrient and total fish intake at age 8 years and outcome data at age 16 years.
CIs were created by applying finite population correction factor.
Mother smoked at least 1 cigarette per day at any point of time during pregnancy or the child’s first months.
§Father and/or mother born outside of Scandinavia.
kDoctor-diagnosed asthma and/or hay fever in combination with reported allergy to pollen or pets in 1 or both parents.
{Any of the parents smoked at least 1 cigarette per day when the child was age 8 years.
#The child had an isoBMI of at least 30 kg/m2 at age 8 years (age and sex specific cut-off values developed for children under 18 years of age).
**The child used supplements, such as multivitamins, sometimes or regularly at age 8 years.
The child had at least 1 IgE value of 0.35 kU/L or greater against inhalant allergens at age 8 years.
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TABLE E2. Distribution of disease in relation to fish intake and
dietary PUFA and vitamin D at age 8 years
Incident study population* (n 5 1590)
No diseasey Incident ARz Incident NAR§
Total fish
<2 Times/wk 482 208 149
>_2 Times/wk 288 129 87
Oily fish
<1 Time/wk 651 295 213
>_1 Time/wk 119 42 23
Cod/pollock/pike
<1 Time/wk 527 231 153
>_1 Time/wk 237 99 76
Fish fingers
<1 Time/wk 486 198 145
>_1 Time/wk 277 136 88
Total PUFA
Q1 (4.2-7.5) 250 114 82
Q2 (7.5-8.6) 254 108 78
Q3 (8.6-18.8) 266 115 76
ALA
Q1 (0.6-1.0) 253 123 76
Q2 (1.0-1.2) 253 103 82
Q3 (1.2-3.0) 264 111 78
Long-chain n-3 PUFA
Q1 (0.02-0.2) 233 110 103
Q2 (0.2-0.3) 270 107 76
Q3 (0.3-3.6) 267 120 57
n-6 PUFA
Q1 (3.1-5.9) 251 115 80
Q2 (5.9-6.8) 253 111 79
Q3 (6.8-15.1) 266 111 77
LA
Q1 (3.1-5.8) 251 114 80
Q2 (5.8-6.8) 253 111 79
Q3 (6.8-15.0) 266 112 77
AA
Q1 (0.02-0.06) 246 109 91
Q2 (0.06-0.08) 278 112 70
Q3 (0.08-0.28) 246 116 75
n-6/n-3 ratio
Q1 (1.5-4.3) 281 109 66
Q2 (4.3-4.8) 247 119 85
Q3 (4.8-10.9) 242 109 85
Vitamin D
Q1 (1.5-4.5) 246 117 83
Q2 (4.5-6.0) 263 118 71
Q3 (6.0-24.1) 261 102 82
*No rhinitis symptoms at age 8 years.
Adolescents without sensitization and rhinitis symptoms at age 16 years (reference
group in association analyses).
Adolescents with sensitization and rhinitis symptoms at age 16 years.
§Adolescents with no sensitization but rhinitis symptoms at age 16 years.
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